Compare EBF & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EBF | CRMD |
|---|---|---|
| Founded | 1909 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Office Equipment/Supplies/Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 538.9M | 590.7M |
| IPO Year | 1994 | 2009 |
| Metric | EBF | CRMD |
|---|---|---|
| Price | $22.60 | $7.52 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $15.33 |
| AVG Volume (30 Days) | 124.3K | ★ 686.8K |
| Earning Date | 09-21-2026 | 11-11-2026 |
| Dividend Yield | ★ 4.67% | N/A |
| EPS Growth | 7.79 | ★ 780.00 |
| EPS | 0.39 | ★ 0.72 |
| Revenue | N/A | ★ $311,709,000.00 |
| Revenue This Year | $1.01 | $8.13 |
| Revenue Next Year | $0.92 | N/A |
| P/E Ratio | $58.06 | ★ $11.00 |
| Revenue Growth | N/A | ★ 617.03 |
| 52 Week Low | $16.30 | $6.13 |
| 52 Week High | $22.94 | $13.02 |
| Indicator | EBF | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 67.01 | 41.95 |
| Support Level | $20.81 | $7.50 |
| Resistance Level | $22.94 | $8.97 |
| Average True Range (ATR) | 0.40 | 0.20 |
| MACD | 0.12 | -0.01 |
| Stochastic Oscillator | 87.50 | 10.62 |
Ennis Inc is a trade printer company that manufactures a broad range of printed products throughout the United States. It is engaged in the business of manufacturing, designing, and selling business forms and other printed business products to distributors located in the United States. Through a network of independent distributors, its channel encompasses independent print distributors, commercial printers, direct mail, fulfillment companies, payroll and accounts payable software companies, and advertising agencies, among others. The group operates in a single reportable segment called Print and derives its operating revenues from the manufacturing of mostly custom or semi-custom printed products sold mostly to independent distributors in the United States.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.